Tom Scheidt starts a new Position as PI at the Luxembourg Centre for Systems Biomedicine
A great milestone for innovation in next-generation cancer therapies. Congratulations to everyone involved!
Read more in the following press release:
https://www.veraxa.com/press-release/veraxa-biotech-to-debut-as-a-publicly-traded-company-pioneering-next-generation-cancer-therapies-on-june-11-2026